ARALAST Side Effects

6930081-2 |
on Aug 11, 2010 Female patient from UNITED STATES , 51 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

6809502-1 | Diarrhoea, Fatigue
Patient was taking Aralast (View Usage). Patient had the following side effects: diarrhoea, fatigue on Jun 24, 2010 from UNITED STATES Additional patient health information: Female patient , 70 years of age, weighting 176.4 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Aralast dosage: .

6733295-X | Diarrhoea, Fatigue
Adverse event was reported on May 10, 2010 by a Female patient taking Aralast (View Usage) (Dosage: ) was diagnosed with alpha-1 anti-trypsin deficiency and. Location: UNITED STATES , 70 years of age, weighting 176.4 lb, After Aralast was administered, patient had the following side effects: diarrhoea, fatigue.

6638426-8 | Bacteraemia, Chills, Mycobacterium Fortuitum Infection, Pyrexia
on Mar 09, 2010 Male patient from UNITED STATES , 50 years of age, weighting 242.5 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, chills, mycobacterium fortuitum infection, pyrexia. Aralast dosage: . During the same period patient was treated with SEREVENT (View Serevent Review and Serevent Label ), QVAR 40 (View Qvar 40 Review and Qvar 40 Label ), PROVAR (View Provar Review and Provar Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ).


6593747-2 | Bacteraemia, Chills, Mycobacterial Infection, Pyrexia
on Feb 11, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). Patient had the following side effects: bacteraemia, chills, mycobacterial infection, pyrexia. Aralast dosage: .

6542392-3 | Infusion Related Reaction, Lung Disorder
Patient was taking Aralast (View Usage). After Aralast was administered, patient had the following side effects: infusion related reaction, lung disorder on Jan 14, 2010 from UNITED STATES Additional patient health information: Male patient , 40 years of age, weighting 181.9 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Aralast dosage: 5240mg Weekly Iv Drip.

6532454-9 | Chronic Obstructive Pulmonary Disease
Adverse event was reported on Apr 07, 2009 by a Male patient taking Aralast (View Usage) (Dosage: ) was diagnosed with alpha-1 anti-trypsin deficiency and. Location: UNITED STATES , 50 years of age, weighting 244.7 lb, Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease. Patient was hospitalized.

6453131-9 |
on Nov 17, 2009 Female patient from UNITED STATES , 51 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

6417836-8 | Chronic Obstructive Pulmonary Disease, Condition Aggravated, Cubital Tunnel Syndrome, Gastrooesophageal Reflux Disease, Left Ventricular Hypertrophy, Lordosis, No Therapeutic Response, Pneumonia
on Oct 19, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). After Aralast was administered, patient had the following side effects: chronic obstructive pulmonary disease, condition aggravated, cubital tunnel syndrome, gastrooesophageal reflux disease, left ventricular hypertrophy, lordosis, no therapeutic response, pneumonia (What is pneumonia?). Aralast dosage: . During the same period patient was treated with FISH OIL (View Fish Oil Review and Fish Oil Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ATUSS DM (View Atuss Dm Review and Atuss Dm Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), PROZAC (View Prozac Review and Prozac Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), XOPENEX (View Xopenex Review and Xopenex Label ).

6383336-7 | Dyspnoea, Pulmonary Toxicity
Patient was taking Aralast (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, pulmonary toxicity on Sep 22, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 174.2 lb, was diagnosed with alpha-1 anti-trypsin deficiency, chronic obstructive pulmonary disease, rhinitis allergic and. Aralast dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), ACTIVELLA (View Activella Review and Activella Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ).

6332580-3 | Dyspnoea, Pulmonary Toxicity
Adverse event was reported on Aug 19, 2009 by a Female patient taking Aralast (View Usage) (Dosage: ) was diagnosed with alpha-1 anti-trypsin deficiency, chronic obstructive pulmonary disease, rhinitis allergic and. Location: UNITED STATES , 56 years of age, weighting 174.2 lb, Patient had the following side effects: dyspnoea, pulmonary toxicity. During the same period patient was treated with ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), ACTIVELLA (View Activella Review and Activella Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ).

6276138-3 | Alopecia
on Jul 20, 2009 Male patient from UNITED STATES , 73 years of age, weighting 158.7 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). After Aralast was administered, patient had the following side effects: alopecia. Aralast dosage: 4800 Mg +/- 10% Weekly Iv.

6265302-5 | Asthenia, Chills, Dyspnoea, Pyrexia, Sepsis
on Jul 02, 2009 Male patient from UNITED STATES , 49 years of age, was diagnosed with alpha-1 anti-trypsin deficiency, dyspnoea and was treated with Aralast (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, chills, dyspnoea, pyrexia, sepsis (What is sepsis?). Aralast dosage: . Patient was hospitalized.

6220522-0 |
Patient was taking Aralast (View Usage). on Jun 03, 2009 from UNITED STATES Additional patient health information: Male patient , 59 years of age, . Aralast dosage: .

6218089-6 | External Ear Pain, Sinusitis, Temporal Arteritis, Vomiting
Adverse event was reported on May 28, 2009 by a Female patient taking Aralast (View Usage) (Dosage: ) was diagnosed with inborn error of metabolism and. Location: UNITED STATES , 63 years of age, weighting 231.5 lb, After Aralast was administered, patient had the following side effects: external ear pain, sinusitis (What is sinusitis?), temporal arteritis, vomiting. During the same period patient was treated with PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), AVALIDE (View Avalide Review and Avalide Label ), DETROL (View Detrol Review and Detrol Label ), XYZAL (View Xyzal Review and Xyzal Label ), NASONEX (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

6213910-X |
on May 27, 2009 Male patient from UNITED STATES , 51 years of age, was diagnosed with alpha-1 anti-trypsin deficiency, anaemia and was treated with Aralast (View Usage). . Aralast dosage: . During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), PROCRIT (View Procrit Review and Procrit Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), CIPRO (View Cipro Review and Cipro Label ).

6182289-4 |
on Apr 28, 2009 Female patient from UNITED STATES , 52 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). . Aralast dosage: .

6182287-0 |
Patient was taking Aralast (View Usage). on Apr 28, 2009 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and. Aralast dosage: .

6163070-9 |
Adverse event was reported on Apr 14, 2009 by a Female patient taking Aralast (View Usage) (Dosage: ) . Location: UNITED STATES , 52 years of age, .

6156445-5 | External Ear Pain, Sinusitis, Temporal Arteritis, Vomiting
on Apr 06, 2009 Female patient from UNITED STATES , 63 years of age, weighting 231.5 lb, was diagnosed with inborn error of metabolism and was treated with Aralast (View Usage). Patient had the following side effects: external ear pain, sinusitis (What is sinusitis?), temporal arteritis, vomiting. Aralast dosage: . During the same period patient was treated with PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), AVALIDE (View Avalide Review and Avalide Label ), DETROL (View Detrol Review and Detrol Label ), XYZAL (View Xyzal Review and Xyzal Label ), NASONEX (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

6143078-X |
on Mar 26, 2009 Female patient from UNITED STATES , 36 years of age, was diagnosed with chronic obstructive pulmonary disease, alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). . Aralast dosage: .

6141375-5 |
Patient was taking Aralast (View Usage). on Mar 26, 2009 from UNITED STATES Additional patient health information: Male patient , 50 years of age, . Aralast dosage: .

6141334-2 |
Adverse event was reported on Mar 25, 2009 by a Male patient taking Aralast (View Usage) (Dosage: ) . Location: UNITED STATES , 62 years of age, .

6140179-7 |
on Mar 25, 2009 Female patient from UNITED STATES , 52 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

6123828-9 |
on Mar 11, 2009 Male patient from UNITED STATES , 57 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

6063546-9 |
Patient was taking Aralast (View Usage). on Jan 29, 2009 from UNITED STATES Additional patient health information: Female patient , 86 years of age, . Aralast dosage: .

6057551-6 |
Adverse event was reported on Jan 20, 2009 by a Male patient taking Aralast (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, .

6052792-6 |
on Jan 21, 2009 Female patient from UNITED STATES , 72 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

6052226-1 | Anaphylactic Reaction, Myocardial Infarction
on Jan 19, 2009 Female patient from UNITED STATES , 63 years of age, weighting 185.2 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). Patient had the following side effects: anaphylactic reaction, myocardial infarction. Aralast dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), METHYLPHENIDATE HCL (View Methylphenidate Hcl Review and Methylphenidate Hcl Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), POTASSIUM (View Potassium Review and Potassium Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6013034-0 |
Patient was taking Aralast (View Usage). on Dec 10, 2008 from UNITED STATES Additional patient health information: Female patient , 72 years of age, . Aralast dosage: .

6012998-9 |
Adverse event was reported on Dec 09, 2008 by a Female patient taking Aralast (View Usage) (Dosage: ) . Location: UNITED STATES , 86 years of age, .

5981830-1 | Anxiety, Hypoaesthesia, Respiratory Rate Increased
on Nov 24, 2008 Female patient from UNITED STATES , weighting 121.3 lb, was diagnosed with alpha-1 anti-trypsin deficiency, chronic obstructive pulmonary disease and was treated with Aralast (View Usage). Patient had the following side effects: anxiety (What is anxiety?), hypoaesthesia, respiratory rate increased. Aralast dosage: . Patient was hospitalized.

5981820-9 | Anxiety, Hypoaesthesia, Respiratory Rate Increased
on Nov 24, 2008 Female patient from UNITED STATES , weighting 121.3 lb, was diagnosed with alpha-1 anti-trypsin deficiency, chronic obstructive pulmonary disease and was treated with Aralast (View Usage). After Aralast was administered, patient had the following side effects: anxiety (What is anxiety?), hypoaesthesia, respiratory rate increased. Aralast dosage: . Patient was hospitalized.

5964076-2 | Tuberculosis
Patient was taking Aralast (View Usage). Patient experienced the following unwanted or unexpected effects: tuberculosis (What is tuberculosis?) on Nov 17, 2008 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Aralast dosage: .

5955564-3 | Anaphylactic Reaction, Myocardial Infarction
Adverse event was reported on Nov 06, 2008 by a Female patient taking Aralast (View Usage) (Dosage: ) was diagnosed with alpha-1 anti-trypsin deficiency and. Location: UNITED STATES , 63 years of age, weighting 185.2 lb, Patient had the following side effects: anaphylactic reaction, myocardial infarction. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), METHYLPHENIDATE HCL (View Methylphenidate Hcl Review and Methylphenidate Hcl Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5931088-4 | Tuberculosis
on Oct 17, 2008 Male patient from UNITED STATES , 46 years of age, was treated with Aralast (View Usage). After Aralast was administered, patient had the following side effects: tuberculosis (What is tuberculosis?). Aralast dosage: .

5931065-3 | Dehydration, Lung Disorder, Oxygen Saturation Abnormal
on Oct 17, 2008 Male patient from UNITED STATES , 62 years of age, weighting 127.9 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, lung disorder, oxygen saturation abnormal. Aralast dosage: . Patient was hospitalized.

5900579-4 | Asthenia, Cardiac Disorder, Malaise
Patient was taking Aralast (View Usage). Patient had the following side effects: asthenia, cardiac disorder, malaise on Sep 17, 2008 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 132.3 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Aralast dosage: . During the same period patient was treated with BERIVA (View Beriva Review and Beriva Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5900568-X |
Adverse event was reported on Sep 17, 2008 by a Male patient taking Aralast (View Usage) (Dosage: ) . Location: UNITED STATES , 66 years of age, .

5864676-4 |
on Aug 21, 2008 Male patient from UNITED STATES , 62 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

5845587-7 |
on Aug 05, 2008 Male patient from UNITED STATES , 47 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

5765206-8 | Catheter Related Complication, Chills, Headache, Infusion Related Reaction, Tremor, Urticaria
Patient was taking Aralast (View Usage). After Aralast was administered, patient had the following side effects: catheter related complication, chills, headache (What is headache?), infusion related reaction, tremor, urticaria on Jun 10, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 202.8 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Aralast dosage: 5520 Mg Once - 10% Qweek Iv. Patient was hospitalized.

5749856-0 |
Adverse event was reported on May 16, 2008 by a Female patient taking Aralast (View Usage) (Dosage: ) . Location: UNITED STATES , 73 years of age, .

5745710-9 |
on May 13, 2008 Male patient from UNITED STATES , 51 years of age, was treated with Aralast (View Usage). . Aralast dosage: .

5692370-1 | Pain In Jaw, Resorption Bone Increased
on Mar 27, 2008 Male patient from UNITED STATES , 60 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). After Aralast was administered, patient had the following side effects: pain in jaw, resorption bone increased. Aralast dosage: .

5660956-6 | Cardiac Arrest, Respiratory Failure
Patient was taking Aralast (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), respiratory failure on Feb 29, 2008 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 123.5 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Aralast dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), COMBIVENT /GFR/ (View Combivent /gfr/ Review and Combivent /gfr/ Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized.

5651749-4 | Feeling Abnormal, Lethargy, Pancreatitis, Somnolence
Adverse event was reported on Feb 27, 2008 by a Male patient taking Aralast (View Usage) (Dosage: ) was diagnosed with alpha-1 anti-trypsin deficiency, gout (What is gout?), blood cholesterol, blood pressure (What is blood pressure?), blood triglycerides, lung disorder and. Location: UNITED STATES , 71 years of age, weighting 194.0 lb, Patient had the following side effects: feeling abnormal, lethargy, pancreatitis, somnolence. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), OMACOR (View Omacor Review and Omacor Label ), SEREVENT (View Serevent Review and Serevent Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

5534591-4 | Amnesia, Confusional State, Fatigue, Road Traffic Accident
on Nov 26, 2007 Female patient from UNITED STATES , 60 years of age, weighting 163.1 lb, was diagnosed with alpha-1 anti-trypsin deficiency, discomfort and was treated with Aralast (View Usage). After Aralast was administered, patient had the following side effects: amnesia, confusional state, fatigue, road traffic accident. Aralast dosage: . During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ESTROGENS (View Estrogens Review and Estrogens Label ), IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), EXCEDRIN (MIGRAINE) (View Excedrin (migraine) Review and Excedrin (migraine) Label ), NASONEX (View Nasonex Review and Nasonex Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized.

5530849-3 | Cardiac Arrest, Respiratory Failure
on Nov 19, 2007 Male patient from UNITED STATES , 39 years of age, weighting 123.5 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Aralast (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), respiratory failure. Aralast dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), COMBIVENT /GFR/ (View Combivent /gfr/ Review and Combivent /gfr/ Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized.

5521234-9 | Cardiac Arrest, Respiratory Failure
Patient was taking Aralast (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory failure on Nov 08, 2007 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 123.5 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Aralast dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), COMBIVENT /GFR/ (View Combivent /gfr/ Review and Combivent /gfr/ Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized.